Qubit Pharmaceuticals’ Post

View organization page for Qubit Pharmaceuticals, graphic

6,776 followers

🚀 Major breakthrough in quantum algorithms: Qubit Pharmaceuticals and Sorbonne Université drastically reduce the number of qubits needed to simulate molecules - from over 250 to just 20! We're thrilled to announce that this achievement, powered by our Hyperion-1 emulator, has secured €8 million in funding from the France 2030 plan within the i-Démo programme, powered by Bpifrance and Secretary general for investment. 🌟 We'd like to thank all the partners involved - especially Sorbonne Université, Scaleway & GENCI - this milestone brings us closer to the practical application of hybrid HPC-quantum computing in drug discovery, reinforcing our goal to pioneer molecular modeling-based drug discovery. Find out all the details and statements in the press release below! #QuantumforPharma #QuantumComputing #DrugDiscovery #idemo

Major breakthrough in quantum algorithms: 
Qubit Pharma and Sorbonne University drastically reduce the number of qubits needed to simulate molecules

Major breakthrough in quantum algorithms: Qubit Pharma and Sorbonne University drastically reduce the number of qubits needed to simulate molecules

Qubit Pharmaceuticals on LinkedIn

Very proud at GENCI to support since many years the development of Qubit Pharmaceuticals with our #HPC, #AI and now #QC computing facilites. Look forward for the next joint adventure on the new partition of Jean Zay (at IDRIS CNRS - Centre national de la recherche scientifique) and on our Pasqal quantum computer at TGCC (CEA) 🚀

Brice Elmoznino

International Senior Adviser, Marketing & Communication

1mo

I have an AI "hallucination" when I read that ONLY €8Million are being offered by major contributors, outrageous partners and the french government to reinforce a deep tech company specialising in the discovery of new drug candidates through molecular simulation using NEW Quantum computing technology. 👎 Becoming a pharma leader in Europe and France in the coming years will need higher investments. The multidisciplinary team, led by CEO Robert Marino, and the founders are based in France at the Paris Santé Cochin incubator and in the USA in Boston. For more information, or to join the ambitious team, visit www.qubit-pharmaceuticals.com

Like
Reply
Rachelle Bienstock

Structure Based /Computer Aided Drug Design

1mo

Congratulations

Konstantinos Meichanetzidis

Head of Product Development at Quantinuum

1mo

Where paper?

Is the methodology published? Can you share the link?

Scaleway is delighted to be part of this great adventure! cc Sébastien Luttringer Amaury Simon - JM

Hervé SIENDT, PhD, PMP

Senior Scientist in Medicinal Chemistry - Looking for new role in Pharma Industry

1mo

Curious to see the gain in prediction accuracy you might get (still in a reasonable computing-time) compared with traditional Forcefield-based systems. Interesting times ahead !

Like
Reply
Olivier Nosjean

Head of Global Scientific Affairs, Public Affairs at Servier

1mo

Big congrats to Robert Marino and the QuBit team! Pharma companies are very much expecting quantum computing to enhance our drug discovery capabilities!

Christophe Thioux

Vice President Mid-Market Sales EMEA at Equinix / Board Member La French Tech Amsterdam

1mo

Amazing!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics